drugset / Trial / NCT01882322
A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to compare the efficacy and safety between a group that has been on Prograf twice daily therapy but converted to Advagraf once daily therapy and a group that maintained Prograf twice daily therapy.
Timeline
- Start
- 2013-01-30
- Primary completion
- 2017-01-03
- Completion
- 2017-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | — | Oral |
Indications
No indication recorded.